MEDICAID TO REVISE AMP REIMBURSEMENT FOR GENERICS

Published Online: Saturday, July 1, 2006
Follow Pharmacy_Times:

Incentives built into the new Medicare Part D drug plan to increase the use of generic drugs are driving down program costs significantly, according to the results of a new study. Researchers at Verispan found that 55% of all prescriptions being filled by Medicare patients during the first 3 months of the new program were for generic drugs.

Teva Pharmaceuticals was the leading supplier of drugs for Medicare recipients enrolled in Part D. Four other generic manufacturers—Mylan Pharmaceuticals, Watson Pharmaceuticals Inc, IVAX Pharmaceuticals Inc, and Mallinckrodt Medical—also ranked among the top 10, the researchers said.




Related Articles
No Result Found
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$
VSEO N/A